TY - JOUR
T1 - A Phosphomimetic Mutation Stabilizes SOD1 and Rescues Cell Viability in the Context of an ALS-Associated Mutation
AU - Fay, James M.
AU - Zhu, Cheng
AU - Proctor, Elizabeth A.
AU - Tao, Yazhong
AU - Cui, Wenjun
AU - Ke, Hengming
AU - Dokholyan, Nikolay V.
N1 - Funding Information:
We thank Dr. Michael Caplow, Dr. Feng Ding, and Dr. Marino Convertino for valuable discussions. We also thank Dr. Rachel Redler and Dr. Lanette Fee for outstanding support of the study. This work was supported by NIH Grant R01GM080742 (to N.V.D.). E.A.P. was supported by a Ruth L. Kirschstein National Research Service Award ( F31AG039266 ) from the National Institute on Aging .
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/11/1
Y1 - 2016/11/1
N2 - The majority of amyotrophic lateral sclerosis (ALS)-related mutations in the enzyme Cu,Zn superoxide dismutase (SOD1), as well as a post-translational modification, glutathionylation, destabilize the protein and lead to a misfolded oligomer that is toxic to motor neurons. The biophysical role of another physiological SOD1 modification, T2-phosphorylation, has remained a mystery. Here, we find that a phosphomimetic mutation, T2D, thermodynamically stabilizes SOD1 even in the context of a strongly SOD1-destabilizing mutation, A4V, one of the most prevalent and aggressive ALS-associated mutations in North America. This stabilization protects against formation of toxic SOD oligomers and positively impacts motor neuron survival in cellular assays. We solve the crystal structure of T2D-SOD1 and explain its stabilization effect using discrete molecular dynamics (DMD) simulations. These findings imply that T2-phosphorylation may be a plausible innate cellular protection response against SOD1-induced cytotoxicity, and stabilizing the SOD1 native conformation might offer us viable pharmaceutical strategies against currently incurable ALS.
AB - The majority of amyotrophic lateral sclerosis (ALS)-related mutations in the enzyme Cu,Zn superoxide dismutase (SOD1), as well as a post-translational modification, glutathionylation, destabilize the protein and lead to a misfolded oligomer that is toxic to motor neurons. The biophysical role of another physiological SOD1 modification, T2-phosphorylation, has remained a mystery. Here, we find that a phosphomimetic mutation, T2D, thermodynamically stabilizes SOD1 even in the context of a strongly SOD1-destabilizing mutation, A4V, one of the most prevalent and aggressive ALS-associated mutations in North America. This stabilization protects against formation of toxic SOD oligomers and positively impacts motor neuron survival in cellular assays. We solve the crystal structure of T2D-SOD1 and explain its stabilization effect using discrete molecular dynamics (DMD) simulations. These findings imply that T2-phosphorylation may be a plausible innate cellular protection response against SOD1-induced cytotoxicity, and stabilizing the SOD1 native conformation might offer us viable pharmaceutical strategies against currently incurable ALS.
UR - http://www.scopus.com/inward/record.url?scp=84993968490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84993968490&partnerID=8YFLogxK
U2 - 10.1016/j.str.2016.08.011
DO - 10.1016/j.str.2016.08.011
M3 - Article
C2 - 27667694
AN - SCOPUS:84993968490
SN - 0969-2126
VL - 24
SP - 1898
EP - 1906
JO - Structure
JF - Structure
IS - 11
ER -